Capgemini Invent

On World Environment Day, the ambition is clear. The focus now is on turning net zero into measurable action. Our approach is deliberate and built around three priorities: reducing carbon, protecting resources, and scaling impact beyond our own footprint. - Cutting carbon: By transitioning to renewable electricity, improving site efficiency, reducing travel, and lowering emissions across our supply chain, while investing in both nature-based and technological climate solutions - Protecting resources: By reducing waste and advancing circular practices, conserving water and increasing reuse, and minimizing our impact on biodiversity across our operations and supplier network - Driving collective impact: By partnering with NGOs and industry bodies, supporting our clients in their sustainability journeys, and enabling our local teams to turn global goals into action on the ground Explore our net zero report, 5 years on our road to net zero: https://bit.ly/43Umc4Q #WorldEnvironmentDay

A decade ago, VivaTech was about what could be. For this 10th edition, we’re moving beyond the hype. June 17–20 | Hall 7.3 | Booth 3B36 We’ll be showcasing how innovation translates into real outcomes through live demonstrations and collaborations with startups already transforming business at scale. From trusted AI and disinformation resilience to agentic commerce, industrial operations, and next-gen robotics the priority is clear: making innovation usable, scalable, and accountable. If you’re at VivaTech, let’s connect and explore what’s truly ready to scale: https://bit.ly/4cCE7m2 #Innovation #MakeItReal

Solar Team Twente’s mission has always been to build the world’s most efficient solar car. However, as the team reached new heights in solar technology, a shift was needed to continue advancing. Capgemini’s strategic partnership helped the team pivot from asphalt racing to rally racing, providing an opportunity to apply their innovations in extreme environments like the Rallye du Maroc 2026, where they will test their solar car’s capabilities in the desert.   This collaboration is not just about racing; it’s about revolutionizing sustainable mobility and applying solar technology in some of the world’s harshest environments.   Discover how Solar Team Twente is embracing the future of solar-powered mobility: https://bit.ly/43zFa0A

The conversation around AI is shifting from capability to responsibility.   AI agents are no longer just generating outputs. They are increasingly taking action within workflows, operating with delegated authority that must be clearly defined and governed.   The latest World Economic Forum report, in collaboration with Capgemini, introduces the Agent Capability and Authorization Profile (ACAP): a framework to make AI delegation explicit, auditable, and scalable.   It helps organizations: ▪Define clear guidelines and boundaries for agent behaviour ▪Enforce what agents are authorized to do ▪Scale from pilots to governed, enterprise-wide deployment   As adoption accelerates, the real challenge isn’t what AI can do, it’s what it should be allowed to do.   Read the report ‘AI Agents in Action: A playbook for trusted adoption, authorization and scaling’: https://bit.ly/3PYasLv   #WEF #MakeItReal

What impact will biosolutions have on our economy and society?   Biosolutions have the potential to deliver something rare: strong economic growth alongside better outcomes for people and the planet. From cleaner labels in food to faster progress in the energy transition, the bioeconomy is set to create tangible benefits for consumers, industries and communities alike.   Capgemini is proud to be a strategic partner of the World Economic Forum.   At Davos earlier this year, we took the opportunity to speak with Andrew Taylor from Novonesis. As an active contributor to the initiative, hear Andrew’s perspective on how biosolutions are shaping the next phase of sustainable, tech‑driven growth.   Find out more about accelerating the tech‑driven bioeconomy: https://bit.ly/4uCkyRi   #MakeItReal #Bioeconomy #WEF

𝐖𝐡𝐚𝐭 𝐢𝐟 𝐲𝐨𝐮𝐫 𝐑&𝐃 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐦𝐨𝐝𝐞𝐥, 𝐧𝐨𝐭 𝐲𝐨𝐮𝐫 𝐬𝐜𝐢𝐞𝐧𝐜𝐞, 𝐢𝐬 𝐬𝐥𝐨𝐰𝐢𝐧𝐠 𝐲𝐨𝐮𝐫 𝐧𝐞𝐱𝐭 𝐛𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡? Pharma R&D is at a crossroads as AI accelerates the convergence between traditional pharma and TechBio. Our latest expert blog is the first of a three-part series: The Pharma Convergence. It explores how TechBio’s data-first model challenges long-standing R&D norms… and what pharma leaders can learn.    The biggest differences show up across three pillars:    1. People: Siloed specialists vs. integrated, cross‑functional teams  2. Process: Sequential, hypothesis‑led workflows vs. AI‑driven learning cycles  3. Technology: Fragmented systems vs. data as a core strategic asset For the authors, Alex Aliper (Insilico Medicine), Ivana Knyght, Justin Melnick, Anoushka Ambrose, and Juhi Singh ,the message is clear: speed now comes from integration, not optimization. 👉 Read the full blog to understand how TechBio is reshaping pharma R&D: https://bit.ly/48ZEqoH And stay tuned for part two on AI and digitization for early drug development. Thorsten Alexander Rall | Dr. Parvin Moyassari